封面
市場調查報告書
商品編碼
1212019

恆溫核酸增幅技術(INAAT)的全球市場

Isothermal Nucleic Acid Amplification Technology (INAAT)

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球恆溫核酸增幅技術(INAAT)的市場規模預測將從2022年的27億美元,到2030年達到60億美元,在2022年~2030年間預計將以10.4%的年複合成長率增長的事。

本報告提供全球恆溫核酸增幅技術(INAAT)市場相關調查分析,提供市場趨勢與推動因素,預測,地區分析,競爭情形等資訊。

調查對像企業範例(全12公司):

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

第4章 競爭

簡介目錄
Product Code: MCP12875

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach $6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.7 Billion in the year 2022, is projected to reach a revised size of US$6 Billion by 2030, growing at aCAGR of 10.4% over the period 2022-2030. Reagents, one of the segments analyzed in the report, is projected to record 10.3% CAGR and reach US$4.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 10.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $793.1 Million, While China is Forecast to Grow at 9.8% CAGR

The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$793.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.3% and 8.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Select Competitors (Total 12 Featured):

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
    • Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of HIV, Hepatitis, and Other Infectious Disease - A Key Factor Propelling the Need for INAAT
    • Global Incidence of HIV by Region: 2017
    • Rising Global Incidence of Cancer Drives the INAAT Market
    • Development of New Technologies to Propel Market Expansion
    • Microfluidic Lab-on-a-chip Technology Aids in Expanding NAAT Use to POCT
    • Global Hepatitis B Incidence and Mortality Rates
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Central & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Active Players in United States
    • TABLE 32: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • Active Players in Japan
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Active Players in China
    • TABLE 59: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • Active Players in France
    • TABLE 80: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • Active Players in Germany
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • Active Players in United Kingdom
    • TABLE 107: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION